fcsb is Bringing the biorevolution to Canada
Crowdfund round 2 extended to June 30th!
We're bringing together stakeholders from coast to coast to push the needle towards making the world a more sustainable place.
You can invest in what’s been done. Or you can invest in what’s possible with Canada’s first private accelerator program specializing in synthetic biology.
Synthetic biology gives us the ability to read, write and reinvent genetic code. Giving humankind an entirely new set of tools to combat planetary issues in sustainability, medicine, agriculture and more. Forest City SynBio provides synthetic biology startups the resources, facilities and network they need to turn London, Ontario into a global hub for synbio innovation.
Investing in ideas
that redefine doable.
in 2022, the world
is banking on synbio.
In 2021, synthetic biology projects saw $18 billion in capital investments and
2022 is predicted to be a record year for synthetic biology investment.
The last quarter of 2021 saw the biggest influx of investments into agriculture and sustainable food companies, which surpassed total investments made in health and medicine in Q4.
At this rate, the global economic impact of synbio is expected
to be worth 2 to 4 trillion dollars by 2030 (McKinsey Global Institute, The Bio Revolution 2020).
As an investor, your opportunity to join is here. Be a part of growing the Canadian technology sector alongside companies poised to reshape global industries for a better and more sustainable future.
Growing an industry
and your portfolio.
Investing in Canada’s burgeoning bioeconomy with Forest City SynBio offers investors equity in a VC fund, and diversifies your portfolio through cutting-edge synbio companies.
Our investors get first notification of potential equity opportunities in Forest City SynBio alum ventures.
You don’t have to be an expert investor to stake your claim in the booming bioeconomy. Forest City SynBio is committed to making investment in the future more accessible by giving everyday people the opportunity to invest in high-impact and high-growth companies.